Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO’s Growth Momentum Strong
HONG KONG, Mar 25, 2025 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, "CanSinoBIO" or the “Company”), a leading player in China's vaccine industry, achieved...
